1. 首都医科大学附属北京中医医院
2. 中国人民解放军第三O七医院
3. 中日友好医院
4. 南昌大学第一附属医院
5. 浙江省中医院
6. 桂林市中医院
纸质出版:2015
移动端阅览
[1]富琦,史琳,许炜茹,杨国旺,江泽飞,张少华,万冬桂,武彪,傅莹,郭勇,杨维泓,卓睿,王笑民.乳腺癌术后高危人群3年复发转移影响因素分析[J].中医杂志,2015,56(04):315-318.
FU Qi, SHI Lin, XU Weiru, et al. Influence Factor Analysis on 3-year Recurrence and Metastasis in High-Risk Postoperative Breast Cancer Patients[J]. Journal of Traditional Chinese Medicine2015, 56(4): 315-318.
[1]富琦,史琳,许炜茹,杨国旺,江泽飞,张少华,万冬桂,武彪,傅莹,郭勇,杨维泓,卓睿,王笑民.乳腺癌术后高危人群3年复发转移影响因素分析[J].中医杂志,2015,56(04):315-318. DOI: 10.13288/j.11-2166/r.2015.04.013.
FU Qi, SHI Lin, XU Weiru, et al. Influence Factor Analysis on 3-year Recurrence and Metastasis in High-Risk Postoperative Breast Cancer Patients[J]. Journal of Traditional Chinese Medicine2015, 56(4): 315-318. DOI: 10.13288/j.11-2166/r.2015.04.013.
目的探讨乳腺癌术后高危人群肿瘤复发、转移的影响因素。方法采用多中心前瞻性研究
对210例乳腺癌术后高危人群从发病年龄、月经情况、病理类型、临床分期、乳腺癌组织激素受体及治疗手段(化疗方案、化疗周期、内分泌药物选择、是否接受中医治疗)等因素对3年复发转移率进行单一因素影响分析。结果乳腺癌术后3年复发转移率与年龄、月经情况、雌激素受体与孕激素受体情况、病理分型无明显相关(P>0.05)。临床分期分析显示
与IIa及IIb期比较
Ⅲc期复发转移率明显增高(P<0.05或P<0.01)
且肿物越大、淋巴结转移越多
3年复发转移率越高(P<0.05)。治疗因素中
与非中医治疗比较
应用中医辨证论治方案治疗患者3年复发转移率明显下降(P<0.01)。分层分析显示
临床分期Ⅲc期、淋巴结转移>9个及人表皮生长因子受体2(HER2)阴性的患者
中医治疗患者3年复发转移率明显下降(P<0.05或P<0.01)。而辅助化疗方案、化疗周期、不同内分泌药物选择等因素与3年复发转移率无明显相关(P>0.05)。结论肿瘤分期、淋巴结转移情况、肿瘤大小、是否接受中医辨证治疗是影响肿瘤复发、转移的主要因素。
Objective To explore the influence factors on tumor recurrence and metastasis in high-risk postoperative breast cancer patients. Methods A multi-center prospective study with 210 cases of high-risk postoperative breast cancer was conducted. Single factor analysis was applied on the factors relevant to 3-year recurrence rate including onset age
menstruation
pathological type
clinical stage
hormone receptor of breast cancer tissue and treatment measures( chemotherapy regimen
chemotherapy cycle
endocrine drugchoice
and acceptance of TCM treatment).Results No significant correlations were found between the 3-year recurrence-metastasis rate and age
menstruation
estrogen receptor
progesterone receptor
and pathological type( P > 0. 05). Analysis on clinical stage showed that the recurrence and metastasis rate in stage Ⅲc cases was significantly higher than that in stages IIa and IIb( P < 0. 05 or P < 0. 01). The volume of the tumor and the number of lymph node metastasis were positively correlated to the 3-year recurrence rate( P < 0. 05). As for treatment factors
the 3-year recurrence rate in patients adopted TCM treatment based on syndrome differentiation was significantly lower than those with no TCM treatment( P < 0. 01). Stratified analysis showed that after TCM treatment
the 3-year recurrence and metastasis rate in cases in stage Ⅲc
with metastasis in more than 9 lymph nodes
and with human epidermal growth factor receptor-2( Cerb-2) negative was significantly decreased( P < 0. 05 or P < 0. 01). But no significant correlation was found between factors such as adjuvant chemotherapy regimen
number of cycles
selection of endocrine therapy
etc. and 3-year recurrence and metastasis rate( P > 0. 05). Conclusion The major influence factors on tumor recurrence and metastasis in patients with breast cancer were clinical stages
lymph nodes metastasis
volume of the tumor and whether took TCM treatments.
0
浏览量
534
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010102007558号